138 related articles for article (PubMed ID: 3007684)
21. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
[TBL] [Abstract][Full Text] [Related]
22. Teniposide alone and in combination chemotherapy in small cell lung cancer.
Giaccone G
Semin Oncol; 1992 Apr; 19(2 Suppl 6):75-80. PubMed ID: 1329229
[TBL] [Abstract][Full Text] [Related]
23. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
24. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Given FT; Stehman FB
Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480
[TBL] [Abstract][Full Text] [Related]
25. Treatment of brain metastases of small cell lung cancer with teniposide.
Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
[TBL] [Abstract][Full Text] [Related]
26. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of teniposide (VM-26) in multiple myeloma.
Tirelli U; Carbone A; Zagonei V; Brema F; Veronesi A; Grigoletto E; Volpe R
Am J Clin Oncol; 1985 Aug; 8(4):329-31. PubMed ID: 3909805
[TBL] [Abstract][Full Text] [Related]
28. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
[TBL] [Abstract][Full Text] [Related]
29. Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26).
Canal P; Bugat R; Chatelut E; Pinel MC; Houin G; Plusquellec Y; Carton M
Eur J Cancer Clin Oncol; 1989 May; 25(5):815-20. PubMed ID: 2737218
[TBL] [Abstract][Full Text] [Related]
30. A case of small cell lung cancer successfully treated with VM26.
Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Morinaga S
Jpn J Clin Oncol; 1986 Jun; 16(2):123-8. PubMed ID: 3016377
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy for patients with relapsed malignant lymphoma using methyl-GAG and teniposide (VM-26).
Warrell RP; Straus DJ; Young CW
Cancer Treat Rep; 1982 May; 66(5):1121-5. PubMed ID: 7044533
[TBL] [Abstract][Full Text] [Related]
32. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Fan Y; Huang ZY; Zhang YP; Sun L
Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
[TBL] [Abstract][Full Text] [Related]
33. Teniposide as single drug therapy for elderly patients affected by small cell lung cancer.
Tummarello D; Isidori P; Pasini F; Cetto G; Cellerino R
Eur J Cancer; 1992; 28A(6-7):1081-4. PubMed ID: 1378289
[TBL] [Abstract][Full Text] [Related]
34. Podophyllotoxins for brain metastases of small cell lung cancer.
Haaxma-Reiche H; Berendsen HH; Postmus PE
J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of teniposide in adenocarcinoma of the lung.
Sørensen JB; Bach F; Dombernowsky P; Hansen HH
Cancer Chemother Pharmacol; 1991; 27(6):487-9. PubMed ID: 2013120
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Bleyer WA; Krivit W; Chard RL; Hammond D
Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
Rodman JH; Abromowitch M; Sinkule JA; Hayes FA; Rivera GK; Evans WE
J Clin Oncol; 1987 Jul; 5(7):1007-14. PubMed ID: 3598607
[TBL] [Abstract][Full Text] [Related]
38. Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
van der Burg ME; ten Bokkel Huinink WW; Vriesendorp R; van Oosterom AT; Neijt JP; Vermorken JB; van Putten WL; Kooiman A
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):997-8. PubMed ID: 3666002
[TBL] [Abstract][Full Text] [Related]
39. Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Splinter TA; Sahmoud T; Festen J; van Zandwijk N; Sörenson S; Clerico M; Burghouts J; Dautzenberg B; Kho GS; Kirkpatrick A; Giaccone G
J Clin Oncol; 1996 Jan; 14(1):127-34. PubMed ID: 8558187
[TBL] [Abstract][Full Text] [Related]
40. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]